Revisiting the issue of access to medicines in Africa: Challenges and recommendations

Yusuff Adebayo Adebisi(University of Ibadan), Ifechukwu Benedict Nwogu(Urban Institute), Aishat Jumoke Alaran(World Health Organization - Nigeria), Abubakar Olaitan Badmos(National Primary Health Care Development Agency), Adeboye Olakunle Bamgboye(Obafemi Awolowo University), Basirat Oluwadamilola Rufai(University of Ibadan), Osaretin Christabel Okonji(University of the Western Cape), Malik O. Malik(University of Ibadan), John Oluwafemi Teibo(Universidade de São Paulo), Samah Faisal Abdalla(University of Khartoum), Don Eliseo Lucero‐Prisno(London School of Hygiene & Tropical Medicine), Mohamed Samai(University of Sierra Leone), Wuraola Akande‐Sholabi(University of Ibadan)
Public Health Challenges
June 1, 2022
Cited by 101Open Access
Full Text

Abstract

Background: Access to safe, effective, affordable, and quality medicines is an essential component of the right to health and is also one of the targets in the global development agenda. In this review article, we extensively discuss the challenges and issues surrounding access to medicines in the African region as well as provides recommendations for ensuring medicines security on the continent. Methods: We conducted narrative review with the use of data reported in published literature, reports, and grey literature available in African countries on topics pertaining access to medicines. The authors also snowballed further data to gather information for this review and narrative synthesis was conducted. Results: Africa faces a double burden of infectious and non-communicable diseases and the need for effective universal access to medicines cannot be deemphasized. However, access to medicines on the continent is not without issues and challenges. Some of which are the high burden of infectious diseases and non-infectious diseases, limited pharmaceutical industries and high costs of raw materials, overdependence on countries abroad for medicines, poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health financing mechanisms, lack of infrastructures and technical know-how, low investment on research and development, and circulation of fake and counterfeit medicines among others. Conclusion: This review reifies that access to medicines in Africa faces numerous challenges and it emphasizes the urgent need to address these issues as the continent geared towards strengthening its health systems for universal health coverage.


Related Papers

No related papers found

Powered by citation graph analysis